Trial · NCT00842075
Pramlintide in Adolescents With Type 1 Diabetes
NCT00842075, Not applicable, Completed, University of Colorado, Denver; results first posted 2012-10-19
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pramlintide in Adolescents With Type 1 Diabetes. Trials, record NCT00842075. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00842075
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pramlintide in Adolescents With Type 1 Diabetes
- NCT number
- NCT00842075
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 10 participants, actual
- Lead sponsor
- University of Colorado, Denver
- Conditions
- Type 1 Diabetes
- Interventions
- pramlintide
- First posted
- 2009-02-12
- Last updated
- 2015-06-23
- Results first posted
- 2012-10-19
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | HbA1c Value After 28 Days | 28 | HbA1c values 28 days after randomization |
| Secondary | Weight Change After 28 Days Intervention Period | 28 days | Mean weight change after 28 days intervention period |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | HbA1c Value After 28 Days | 28 | pilot study | HbA1c % | MEAN |
| SECONDARY | Weight Change After 28 Days Intervention Period | 28 days | kg | MEAN |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| HbA1c Value After 28 Days | 1 Symlin | 7.94 | Standard Deviation 0.71 | HbA1c % | |
| HbA1c Value After 28 Days | 2 Usual Regimen | 8.72 | Standard Deviation 0.44 | HbA1c % | |
| Weight Change After 28 Days Intervention Period | 1 Symlin | -0.84 | Standard Deviation 0.24 | kg | |
| Weight Change After 28 Days Intervention Period | 2 Usual Regimen | 0.04 | Standard Deviation 0.62 | kg |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 1 Symlin | 5 | |
| Overall Study | STARTED | 2 Usual Regimen | 5 | |
| Overall Study | COMPLETED | 1 Symlin | 5 | |
| Overall Study | COMPLETED | 2 Usual Regimen | 5 | |
| Overall Study | NOT COMPLETED | 1 Symlin | 0 | |
| Overall Study | NOT COMPLETED | 2 Usual Regimen | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | 1 Symlin | ||
| Total, all-cause mortality | 2 Usual Regimen | ||
| Total, other adverse events | 1 Symlin | 0 | 0 |
| Total, other adverse events | 2 Usual Regimen | 0 | 0 |
| Total, serious adverse events | 1 Symlin | 0 | 0 |
| Total, serious adverse events | 2 Usual Regimen | 0 | 0 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 19858155 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00842075
GET https://conductscience.org/api/trials/v1/NCT00842075/registered